Optometrists prescribing of certain window glaze materials authorization clarification provision
Impact
The bill is anticipated to have a notable impact on state laws related to healthcare and optometry practices. By formalizing the ability of optometrists to prescribe and recommend specific window glaze materials, the bill could potentially broaden the scope of practice for these professionals. Such a change may lead to improved patient outcomes as optometrists can provide tailored solutions that directly address patients' needs for visual comfort in environments that utilize such materials, particularly for those who are exposed to bright lights or glare.
Summary
SF3637 is a bill that seeks to clarify the authorization for optometrists to prescribe certain window glaze materials. The focus of the bill is to ensure that optometrists have the appropriate authority to recommend and prescribe these specialized materials which can have significant implications for patient care, particularly for those with specific vision needs. This legislative change aims to enhance the role of optometrists in the healthcare system by empowering them to offer a broader range of solutions for their patients' ocular health problems related to environmental and occupational exposure.
Contention
Discussions surrounding SF3637 may involve debates about the expected necessity and implications of granting optometrists this level of prescribing authority. Some stakeholders may argue that enhancing the ability of optometrists could unnecessarily expand their jurisdiction, leading to concerns about training and competency in prescribing materials outside of traditional prescriptions. On the other hand, proponents argue that this change could fill a critical gap in patient care, as optometrists are often the first point of contact for those experiencing visual discomfort related to environmental factors.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.